HomeInsightsResults

Torrent Pharmaceuticals Ltd Quarterly Result

Torrent Pharmaceuticals Ltd Quarterly Result

stocks purchased

₹ 0.0 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

0.0 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 22, 2024

Image

Torrent Pharmaceuticals Ltd

NSE: TORNTPHARM

Net Profit

₹ 453

Last updated on: Nov 22, 2024

Key Highlights

  • The revenue of Torrent Pharmaceuticals Ltd for the Sep '24 is ₹ 2873 crore as compare to the Jun '24 revenue of ₹ 2883 crore. This represent the decline of -0.34686092%.
  • The ebitda of Torrent Pharmaceuticals Ltd for the Sep '24 is ₹ 923 crore as compare to the Jun '24 ebitda of ₹ 928 crore. This represent the decline of -0.5387931%.
  • The net profit of Torrent Pharmaceuticals Ltd for the Sep '24 is ₹ 453 crore as compare to the Jun '24 net profit of ₹ 457 crore. This represent the decline of -0.8752735%.

Results Analysis

Market Price of Torrent Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Torrent Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
21 Nov 20243104.55
19 Nov 20243094.8
18 Nov 20243105.65
14 Nov 20243102.35
13 Nov 20243122.45
12 Nov 20243150.55
11 Nov 20243151.9
08 Nov 20243194.9
07 Nov 20243159.4
06 Nov 20243209.5

Historical Revenue of Torrent Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Torrent Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Torrent Pharmaceuticals Ltd

No data available

* All values are in crore

Torrent Pharmaceuticals Ltd News Hub

News

Volumes spurt at Torrent Pharmaceuticals Ltd counter

Capri Global Capital Ltd, Marico Ltd, Honeywell Automation India Ltd, Laxmi Organic Indust...

Read more

30 Oct 202411:00

News

Torrent Pharma Q2 PAT climbs 17% YoY to Rs 453 crore

Revenue from operations rose 8.60% year on year (YoY) to Rs 2,889 crore in the quarter end...

Read more

26 Oct 202414:13

News

Torrent Pharmaceuticals announces board meeting date

Torrent Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 25...

Read more

10 Oct 202417:21

News

Torrent Pharma's Madhya Pradesh facility concludes GMP inspection with 1 observation

The GMP inspection was conducted from 16 September to 20 September 2024. At the conclusion...

Read more

20 Sep 202414:40

News

Torrent Pharma hits life as Gujarat unit gets EIR from USFDA

Earlier on 12 June 2024, the pharmaceutical company informed that the US FDA had conducted...

Read more

30 Aug 202409:46

News

Torrent Pharmaceuticals announces change in senior management

Torrent Pharmaceuticals announced that Pranav Mehta has been elevated as Executive Directo...

Read more

13 Aug 202411:08

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

Credit Report 2024

dropdown
download

Concalls

July 2024

Transcript

May 2024

Transcript

Feb 2024

Transcript

Aug 2023

Transcript

May 2023

Transcript

Sep 2022

PPT

May 2021

Transcript

Feb 2021

Transcript

Oct 2020

Transcript

July 2020

Transcript

May 2020

Transcript

FAQ's For Torrent Pharmaceuticals Ltd Quarterly Result

What is the EPS of Torrent Pharmaceuticals Ltd stock?

The Earnings Per Share (EPS) of Torrent Pharmaceuticals Ltd is 51.42. An EPS is the amount of net income attributed to each share of a common stock.

How is Torrent Pharmaceuticals Ltd EPS calculated?

The EPS of Torrent Pharmaceuticals Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Torrent Pharmaceuticals Ltd report its EPS?

Torrent Pharmaceuticals Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Torrent Pharmaceuticals Ltd EPS?

Factors that influence the EPS of Torrent Pharmaceuticals Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Torrent Pharmaceuticals Ltd EPS growth indicate future performance?

Yes, consistent growth in Torrent Pharmaceuticals Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*